Table 6.
Time 0 | A. baumannii | E. coli | L. monocytogenes | P. aeruginosa | S. aureus |
---|---|---|---|---|---|
E. occidentalis 10 μL/mL |
83.92 ± 2,17 **** | 20.54 ± 0.07 **** | 0 ± 0 | 0 ± 0 | 2.02 ± 0.74 |
E. occidentalis 20 μL/mL |
86.73 ± 1.16 **** | 46.93 ± 0.87 **** | 79.48 ± 0.36 **** | 13.79 ± 1.00 **** | 31.08 ± 0.73 **** |
E. striaticalyx 10 μL/mL |
35.57 ± 6.98 **** | 0 ± 0 | 8.23 ± 0.69 **** | 0.84 ± 0.20 | 48.25 ± 2.12 **** |
E. striaticalyx 20 μL/mL |
66.66 ± 0.94 **** | 10.36 ± 4.61 **** | 27.16 ± 4.11 **** | 30.67 ± 2.49 **** | 60.46 ± 0.66 **** |
E. stricklandii 10 μL/mL |
5.24 ± 0.65 ** | 1.12 ± 0.40 | 0 ± 0 | 0 ± 0 | 45.20 ± 1.92 **** |
E. stricklandii 20 μL/mL |
46.49 ± 3.62 **** | 1.48 ± 0.27 | 36.86 0.78 **** | 42.66 ± 1.33 **** | 45.16 ± 2.01 **** |
24 h | A. baumannii | E. coli | L. monocytogenes | P. aeruginosa | S. aureus |
E. occidentalis 10 μL/mL |
9.71 ± 0.67 **** | 28.60 ± 1.04 **** | 0 ± 0 | 47.97 ± 0.58 **** | 49.93 ± 0.82 **** |
E. occidentalis 20 μL/mL |
32.45 ± 0.62 **** | 40.35 ± 0.87 **** | 67.75 ± 0.46 **** | 56.20 ± 0.57 **** | 52.42 ± 0.85 **** |
E. striaticalyx 10 μL/mL |
39.11 ± 0.38 **** | 6.35 ± 0.73 **** | 26.38 ± 1.35 **** | 8.18 ± 0.57 **** | 19.40 ± 0.79 **** |
E. striaticalyx 20 μL/mL |
45.23 ± 0.91 **** | 31.21 ± 1.21 **** | 34.14 ± 0.62 **** | 17.43 ± 0.58 **** | 23.29 ± 1.15 **** |
E. stricklandii 10 μL/mL |
25.72 ± 0.83 **** | 0 ± 0 | 0 ± 0 | 9.23 ± 1.37 **** | 29.10 ± 0.89 **** |
E. stricklandii 20 μL/mL |
58.83 ± 0.38 **** | 29.22 ± 0.81 **** | 42.28 ± 0.62 **** | 51.60 ± 0.37 **** | 36.04 ± 0.89 **** |
The percentage of inhibition was calculated using the formula: ODC-ODS/ODC*100, where ODC is the OD of the untreated bacteria, and ODs is the OD of the bacteria treated with samples. Results are reported as the mean ± SD of three experiments. *: p < 0.05, **: p < 0.01, ***: p < 0.001, ****: p < 0.00001 vs. control (inhibition = 0), according to two-way ANOVA followed by Dunnet’s multiple comparison test, at the significance level of p < 0.05.